m+Medelevator.RU
← Поиск публикаций
Research square · 2025

Outcomes of Esophageal Atresia at University Tertiary Hospital of Kigali, Rwanda.

СтатьяПрепринтНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Moneme Chioma, Duru Kimberley, Selden Owen, Twardus Shaina, Gooding Jordan, Habumufasha Jean Pierre, Kanyamuhunga Aimable, Jin Ruyun, Kelly Tracy, Kabagambe Sandra, Ntaganda Edmond

Аннотация

PURPOSE: Mortality associated with EA/TEF has declined in HICs with advances in multidisciplinary care. However, it remains as high as 80% in LMICs. This study examines the current clinical outcomes of neonates with EA/TEF at a tertiary-level hospital in Rwanda following the implementation of care by fellowship-trained pediatric surgeons.

METHODS: A retrospective cohort study of neonates with EA/TEF from January 2015 to December 2023. Patient data were collected from medical logbooks for all patients who received surgical treatment at Centre Hospitalier Universitaire de Kigali, Rwanda. Univariable logistic regression was used to identify factors associated with higher 30-day mortality.

RESULTS: 56 patients were included. All infants were born at term and, on average, arrived 7 days after birth (6.98 ±5.18). Type C was the most common anomaly (68%). Mortality data were only available for 82.1% of patients. Of this subset, the 30-day mortality was 52.2%. Increased odds of mortality were associated with the presence of any congenital anomaly (p <0.05) and specifically a cardiac congenital anomaly (p<0.05).

CONCLUSION: This study provides insights into infants with EA/TEF after implementing specialized surgical care, which has helped reduce mortality compared to other LMICs. Targeted quality improvement initiatives for infants with additional associated congenital anomalies could further improve outcomes.

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты